The combined use of transurethral electrovaporization of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia

Objective To evaluate the clinical value of combining use of transurethral electrovaporization of prostate(TUVP) and transurethral resection of the prostate (TURP) for the treatment of BPH. Methods 602 patients with BPH were treated by combining TUVP and TURP. The data were analyzed retrospectively. Results Mean operative time was 70 min (30-150min). Blood transfusion was needed in 5 patients. The perforation of prostate capsule was occurred in 7 patients. Transurethral resection syndrome(TRUS) were observed in 10 patients. There was no permannent urinary incontinence. Among 602 patients, 378 patient were followed up for 3-120 months. IPSS decreased from 21.1 preoperatively to 7.6 postoperatively and Qmax increased from 10.3 ml/s to 19.3 ml/s. Conclusions Combined use of TUVP and TURP for the treatment of BPH is safe and efficient with low complications.